Maharashtra cancels Johnson & Johnson’s baby powder license
Mumbai:
The Maharashtra Food and Drug Administration (FDA) on Friday revoked Johnson & Johnson Pvt Ltd’s baby powder manufacturing license “in the interest of general public health”.
In a statement, the state government said the company’s product, Johnson’s Baby Powder, can affect the skin of babies.
The regulator said the infant powder samples did not match standard pH values during laboratory testing.
The statement said the action was taken following a concluding report by the Kolkata-based Central Drug Laboratory that concluded “the sample did not conform to IS 5339:2004 for pH testing”.
According to the release, the FDA has sampled Johnson’s Baby Powder from Pune and Nashik for quality testing.
The government analyst declared the samples “substandard” because they did not comply with the IS 5339:2004 specification for infant powder within the tested pH.
The FDA subsequently issued a clear notice to Johnson and Johnson under the Cosmetics Act 1940 and the Code, in addition to issuing instructions for the company to withdraw the said product from the market, the statement said. said.
The company “did not accept the government analyst’s report” and challenged it in court for sending it to the Central Drug Laboratory, it added.
